We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUNTU
626
DELISTED
Hunter Maritime Acquisition Corp. Unit
HUNTU
-600,000
Closed -$6.16M
SHPG
627
DELISTED
Shire pic
SHPG
-17,804
Closed -$3.1M
WR
628
DELISTED
Westar Energy Inc
WR
-562,658
Closed -$30.5M
XTLY
629
DELISTED
Xactly Corporation
XTLY
-100,000
Closed -$1.19M
FENX
630
DELISTED
Fenix Parts, Inc.
FENX
-866,241
Closed -$1.34M
WWAV
631
DELISTED
The WhiteWave Foods Company
WWAV
-1,335,000
Closed -$75M
DO
632
DELISTED
Diamond Offshore Drilling
DO
-978,696
Closed -$16.4M
STL
633
DELISTED
Sterling Bancorp
STL
-200,450
Closed -$4.75M
FGL
634
DELISTED
Fidelity & Guaranty Life
FGL
-220,499
Closed -$6.13M
FDC
635
DELISTED
First Data Corporation
FDC
-142,345
Closed -$2.21M
AHPAU
636
DELISTED
Avista Healthcare Public Acquisition Corp.Units
AHPAU
-2,100,000
Closed -$21.4M
MPACU
637
DELISTED
Matlin & Partners Acquisition Corporation Units
MPACU
-2,500,000
Closed -$25.1M

Similar funds

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.